Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. PRIM
2. ABBV
3. META
4. DPZ
5. IBM
6. CNC
7. KFY
8. SPY
9. MU
10. ENRD

Go back to Oragenics Signs Letter of Intent to License CardioDialysis™ Technology from Sigyn Therapeutics to Target TBI-Induced Systemic Inflammation
ORAGENICS (NYSE: OGEN) Delayed: 0.58 --0 (-0%)
Previous Close $0.58    52 Week High $2.12 
Open $0.58    52 Week Low $0.33 
Day High $0.58    P/E N/A 
Day Low $0.58    EPS $-0.45 
Volume 79       

(AMEX: SIGY) Delayed: 0.04 --0 (-0%)
Previous Close $0.04    52 Week High $ 
Open $0.04    52 Week Low $ 
Day High $0.04    P/E N/A 
Day Low $0.04    EPS $ 
Volume 10,966       

(AMEX: SIGYD) Delayed: 4.75 --0 (-0%)
Previous Close $4.75    52 Week High $ 
Open $0.01    52 Week Low $ 
Day High $4.75    P/E N/A 
Day Low $4.75    EPS $ 
Volume 161,279